Practice of Hereditary ATTR Amyloidosis in Non-endemic Areas of Japan

OBJECTIVE: Hereditary ATTR (ATTRv) amyloidosis was once an incurable disease; however, in recent years, disease-modifying therapies, such as tafamidis and patisiran, have become available. We herein report the medical care situation in an ATTRv amyloidosis non-endemic area of Japan. METHODS: We conf...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsushima, Masaaki, Tarisawa, Monami, Nomura, Taichi, Oshima, Yuki, Yoshino, Masanao, Shibata, Yuka, Wakita, Masahiro, Shirai, Shinichi, Iwata, Ikuko, Yaguchi, Hiroaki, Yabe, Ichiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293005/
https://www.ncbi.nlm.nih.gov/pubmed/36261369
http://dx.doi.org/10.2169/internalmedicine.0091-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293005/
https://www.ncbi.nlm.nih.gov/pubmed/36261369
http://dx.doi.org/10.2169/internalmedicine.0091-22

Ejemplares similares